论文部分内容阅读
目的探讨短暂性脑缺血发作临床路径的实施效果。方法回顾对比2011年1月至12月期间实施临床路径患者与2010年1月至12月未实施临床路径患者的平均住院日、平均住院费用、危险因素干预及其预后等指标。结果实施临床路径后,平均住院日、平均住院费减低,危险因素控制的达标率提高,缺血性脑梗死发生率明显降低。结论对短暂性脑缺血发作实施临床路径可有效规范诊疗措施,可降低住院患者的药费,显著提高患者预后,降低缺血性脑梗死发生率。
Objective To explore the clinical effect of transient ischemic attack. Methods A retrospective comparison was made between the average length of stay, average hospitalization costs, risk factors and their prognosis in patients with clinical pathway between January and December in 2011 and those without clinical pathway in January and December in 2010. Results After the implementation of the clinical pathway, the average length of stay, the average hospitalization fee decreased, the compliance rate of risk factors increased, and the incidence of ischemic cerebral infarction decreased significantly. Conclusion The implementation of clinical pathways for transient ischemic attacks can effectively standardize diagnosis and treatment measures, reduce the hospitalization of patients with drugs, significantly improve the prognosis and reduce the incidence of ischemic cerebral infarction.